Earnings History Data for Albireo Pharma, Inc. (ALBO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Albireo Pharma, Inc.

Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2022	AH	4:05 PM ET (Nov 8)	ALBO	Albireo Pharma, Inc.	431.28	-1.89	-1.86	-1.26	Albireo Pharma GAAP EPS of -$1.92 misses by $0.04, revenue of $9.83M beats by $0.29M [11/8/2022 4:05 PM]	18.69	-3.46 (-15.62%)	22.15	0.0 (0.00%)	16.02 - 37.63	515,285	190,000	1,947
Albireo Pharma GAAP EPS of -$1.92 misses by $0.04, revenue of $9.83M beats by $0.29M [11/8/2022 4:05 PM] Bylvay® (odevixibat) Data Presented at AASLD The Liver Meeting® 2022, Demonstrating Native Liver Survival in Children Across PFIC Types [Nov-07-22 08:30AM] Albireo Reports Q3 2022 Financial Results and Business Update [Nov-08-22 04:01PM] Albireo Pharma (ALBO) Reports Q3 Loss, Tops Revenue Estimates [Nov-08-22 05:35PM] Albireo to Participate in Jefferies London Healthcare Conference [Nov-09-22 08:30AM]
15-08-2022	AH	4:00 PM ET (Aug 15)	ALBO	Albireo Pharma, Inc.	469.05	-2.04	-1.58	-1.90	Albireo Pharma GAAP EPS of -$2.04, revenue of $8.2M [8/15/2022 4:10 PM]	18.00	-6.92 (-27.78%)	19.41	-5.52 (-22.14%)	17.81 - 37.63	2,447,682	220,000	44,000
Albireo Pharma GAAP EPS of -$2.04, revenue of $8.2M [8/15/2022 4:10 PM] Albireo Pharma stock slips ~26% after co cuts FY sales guidance for lead drug Bylvay [8/16/2022 10:02 AM] Despite Lacking Profits Albireo Pharma (NASDAQ:ALBO) Seems To Be On Top Of Its Debt [Aug-12-22 07:23AM] Albireo Reports Q2 2022 Financial Results and Business Update [Aug-15-22 04:05PM] Albireo Pharma (ALBO) Reports Q2 Loss, Misses Revenue Estimates [Aug-15-22 05:25PM] Albireo Pharma Shares Plunge After Q2 Results Misses Profit Estimates [Aug-15-22 05:24PM]
16-05-2022	AH	4:00 PM ET (May 16)	ALBO	Albireo Pharma, Inc.	550.01	-2.19	-2.02	-2.29	Albireo Pharma GAAP EPS of -$2.19 misses by $0.39, revenue of $6.83M misses by $0.42M [5/16/2022 4:24 PM]	22.89	-5.15 (-18.37%)	26.50	-1.54 (-5.49%)	20.30 - 37.86	1,939,651	270,000	9,465
Albireo Pharma GAAP EPS of -$2.19 misses by $0.39, revenue of $6.83M misses by $0.42M [5/16/2022 4:24 PM] Albireo stock plunges on disappointing Q1 result [5/17/2022 11:43 AM] Albireo Reports Q1 2022 Financial Results and Business Update [May-16-22 04:01PM] Albireo Pharma (ALBO) Reports Q1 Loss, Lags Revenue Estimates [May-16-22 05:15PM]
01-03-2022	PM	8:30 AM ET (Mar 1)	ALBO	Albireo Pharma, Inc.	648.92	-0.57	-1.27	-1.30	Albireo Pharma GAAP EPS of -$0.57, revenue of $32.52M [3/1/2022 8:41 AM]	27.55	-5.78 (-17.35%)	33.34	0.0 (0.00%)	20.30 - 38.38	982,432	240,000	200
Albireo Pharma Q4 2021 Earnings Preview [2/28/2022 1:41 PM] Albireo Pharma GAAP EPS of -$0.57, revenue of $32.52M [3/1/2022 8:41 AM] Is a Surprise Coming for Albireo Pharma (ALBO) This Earnings Season? [Feb-28-22 08:42AM] Noema Pharma Appoints Michael Gutch as Chief Financial Officer [Feb-28-22 08:00AM] Albireo Reports Q4 and Year-End 2021 Financial Results and Business Update [Mar-01-22 08:30AM] Albireo Pharma (ALBO) Reports Q4 Loss, Tops Revenue Estimates [Mar-01-22 10:25AM]
04-11-2021	PM	8:30 AM ET (Nov 4)	ALBO	Albireo Pharma, Inc.	586.72	-1.26	0.54	-1.96	Albireo Pharma EPS beats by $2.41, misses on revenue [11/4/2021 8:36 AM]	29.51	-1.78 (-5.69%)	28.00	-3.29 (-10.51%)	27.23 - 43.41	249,267	110,000	3,154
Albireo Pharma Q3 2021 Earnings Preview [11/3/2021 9:52 AM] Albireo Pharma EPS beats by $2.41, misses on revenue [11/4/2021 8:36 AM] Albireo Reports Q3 Financial Results and Business Update [Nov-04-21 08:30AM] Albireo Pharma (ALBO) Reports Q3 Loss, Lags Revenue Estimates [Nov-04-21 09:45AM]
05-08-2021	PM	8:30 AM ET (Aug 5)	ALBO	Albireo Pharma, Inc.	547.05	-1.90	-1.92	-1.38	Albireo Pharma EPS beats by $0.07, beats on revenue [8/5/2021 8:42 AM]	30.05	2.51 (9.11%)	27.55	0.01 (0.04%)	22.78 - 49.00	210,056	270,000	321
Albireo Pharma EPS beats by $0.07, beats on revenue [8/5/2021 8:42 AM] Albireo Reports Q2 Financial Results and Business Update [Aug-05-21 08:30AM] ALBIREO PHARMA (ALBO) Reports Q2 Loss, Misses Revenue Estimates [Aug-05-21 09:35AM]
06-05-2021	PM	8:00 AM ET (May 6)	ALBO	Albireo Pharma, Inc.	580.48	-2.29	-1.72	-2.23		30.19	-0.21 (-0.69%)	30.19	0.0 (0.00%)	22.08 - 49.00	190,481	220,000	4,725
Albireo Reports Q1 Financial Results and Business Update [May-06-21 08:30AM] ALBIREO PHARMA (ALBO) Reports Q1 Loss, Lags Revenue Estimates [May-06-21 09:45AM]
25-02-2021	PM	7:30 AM ET (Feb 25)	ALBO	Albireo Pharma, Inc.	701.66	-1.30	-1.90	-0.57	Albireo Pharma EPS beats by $0.59, beats on revenue [2/25/2021 8:05 AM]	35.28	-1.40 (-3.82%)	37.44	0.76 (2.07%)	11.26 - 49.00	193,798	188,466	1,849
Albireo Pharma EPS beats by $0.59, beats on revenue [2/25/2021 8:05 AM]
05-11-2020	PM		ALBO	Albireo Pharma, Inc.	601.82	-1.96	-1.48	-1.73	Albireo Pharma EPS misses by $0.45, beats on revenue [11/5/2020 7:47 AM]	34.59	2.17 (6.69%)	34.59	0.0 (0.00%)	11.26 - 49.00	121,764	136,000	9,021

06-08-2020	PM		ALBO	Albireo Pharma, Inc.	392.76	-1.38	-1.65	-1.35	Albireo Pharma EPS beats by $0.28, beats on revenue [8/6/2020 7:40 AM]	27.31	3.13 (12.94%)	25.50	1.32 (5.46%)	11.26 - 31.50	180,340	162,362	275